Gentium SpA (GENT) 8.70 0.16

Gentium SpA
(GENT) 8.70 0.16

Last Trade:	8.66	Day Range:	8.59 - 8.96
Trade Time:	11:02AM	52wk Range:	5.31 - 13.69
Prev. Close:	8.50	Market Cap:	129.63M
Open:	8.59	Div Yield:	0
Volume:	5496	PE:
EPS:	0.00

The Latest On GENT

Gentium Provides Update on MAA Process for Defibrotide in Europe 12/29/11 7:30am

Results From Gentium's Treatment IND for Defibrotide Presented at the American Society of Hematology Annual Meeting 12/12/11 4:15pm

Gentium Announces Changes to Board of Directors 12/8/11 4:19pm

Gentium Withdraws New Drug Application for Defibrotide 8/17/11 3:15pm

Gentium Submits New Drug Application to FDA 7/6/11 6:33am

Gentium Signs License and Distribution Agreement for Defibrotide With Medison Pharma Ltd. in Israel and the Palestinian Authority 6/21/11 6:32am

Gentium S.P.A. Files $30M Mixed Securities Shelf -Bloomberg 5/27/11 1:10pm

Gentium Announces Submission of a Marketing Authorization Application for Defibrotide to the European Medicines Agency (GENT) 5/10/11 6:44am

Earnings Scheduled For March 28 (PRGS, CALM, CCM, PVH, GENT, HPJ, NVAX, IDSA, NEWN, OTIV, PEIX, PIP, WYY) 3/28/11 1:10am

STOCKS ON THE MOVE NEW YEAR HIGHS:(BRNC),(OME),(PVSW),(GENT),(CAP) 3/24/11 8:37am

Wedbush Has Outperform On Gentium (GENT) 3/21/11 6:26am

Wedbush Initiates Coverage Of Gentium S.p.A. With Outperform Rating And $16 Fair Value 3/15/11 8:09am

Gentium Provides Update on MAA Process for Defibrotide in Europe 12/29/11

Results From Gentium's Treatment IND for Defibrotide Presented at the American Society of Hematology Annual Meeting 12/12/11

Gentium Announces Changes to Board of Directors 12/8/11

Gentium Withdraws New Drug Application for Defibrotide 8/17/11

Gentium Submits New Drug Application to FDA 7/6/11

Gentium Signs License and Distribution Agreement for Defibrotide With Medison Pharma Ltd. in Israel and the Palestinian Authority 6/21/11

Gentium S.P.A. Files $30M Mixed Securities Shelf -Bloomberg 5/27/11

Gentium Announces Submission of a Marketing Authorization Application for Defibrotide to the European Medicines Agency (GENT) 5/10/11

Earnings Scheduled For March 28 (PRGS, CALM, CCM, PVH, GENT, HPJ, NVAX, IDSA, NEWN, OTIV, PEIX, PIP, WYY) 3/28/11

STOCKS ON THE MOVE NEW YEAR HIGHS:(BRNC),(OME),(PVSW),(GENT),(CAP) 3/24/11

Wedbush Has Outperform On Gentium (GENT) 3/21/11

Wedbush Initiates Coverage Of Gentium S.p.A. With Outperform Rating And $16 Fair Value 3/15/11

STOCKS ON THE MOVE NEW YEAR HIGHS:(BRNC),(OME),(PVSW),(GENT),(CAP) 3/24/11

Top Narrow Based Indexes For April 9 (CASY, GENT, EFUT) 4/9/10

Top Narrow Based Indexes For April 1 (GENT, LENS, LIHR) 4/1/10

Gentium S.p.A. (GENT) May Face Some Profit Booking Before Forming A New 52 Week High 4/1/10

Top Performing Industries For March 19 (CNC, HANS, CAJ, BBY, GENT) 3/19/10

Wedbush Has Outperform On Gentium (GENT) 3/21/11

Wedbush Initiates Coverage Of Gentium S.p.A. With Outperform Rating And $16 Fair Value 3/15/11

Trade GENT
NOW!

Partner Headlines

Top Gainers of More Than 30% Within One Day 1/19/12

10 Top-Rated Buys Under $10 6/14/11

10 Stocks Under $10 With Upside 5/6/11

10 Health Care Stocks With Upside: Analysts 4/14/11

Air Transport Services, Borders: Early Volume Movers 4/1/10

Poniard, Xfone: Early Volume Plays 3/24/10

Press Releases

Gentium Appoints Swedish Orphan Biovitrum AB as Exclusive Distributor of Defibrotide in Nordic and Baltic Territories 1/9/12 GlobeNewswire Story

Gentium Provides Update on MAA Process for Defibrotide in Europe 12/29/11 GlobeNewswire Story

Results From Gentium's Treatment IND for Defibrotide Presented at the American Society of Hematology Annual Meeting 12/12/11 GlobeNewswire Story

Gentium Announces Changes to Board of Directors 12/8/11 GlobeNewswire Story

Updated Results From Gentium's Treatment IND for Defibrotide to be Presented at the American Society of Hematology 11/29/11 GlobeNewswire Story

Gentium Announces Establishment of Commercial Infrastructure and Appointment of Commercial Leadership Team 11/22/11 GlobeNewswire Story

Gentium Reports Third Quarter 2011 Financial Results 11/15/11 GlobeNewswire Story

Gentium Withdraws New Drug Application for Defibrotide 8/30/11 GlobeNewswire Story

Gentium Announces Management Change 8/30/11 GlobeNewswire Story

Gentium to Review First Half 2011 Financial Results 8/30/11 GlobeNewswire Story

Gentium Provides Update on MAA Process for Defibrotide in Europe 8/30/11 GlobeNewswire Story

Gentium Reports First Half 2011 Financial Results 8/30/11 GlobeNewswire Story

Get the latest GENT stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Gentium SpA stock price.

Gentium SpA by YCharts

Gentium SpA (GENT) 8.70 0.16

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On GENT

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social